AI-Native Lab Tools: Sell the Capability, Not the Buzzword

by Stephen Manobiano | Jun 30, 2026 | AI, Commercialization, Marketing, news, Sales

Every instrument vendor, every kit company, and every informatics platform now claims to be “AI-powered.” Which means the phrase has stopped doing any commercial work for you. Technical buyers have heard it enough times that it now triggers skepticism instead of...

Single-Cell and 3D/Organoid Systems: Two Markets Wearing One Label

by Stephen Manobiano | Jun 30, 2026 | Commercialization, Marketing, news, Sales

Cell biology is the largest single technology segment in the life science tools market, and “cell biology” is exactly the kind of label that flattens two very different sales motions into one generic pitch. Single-cell sequencing resolves heterogeneity inside a...

Spatial Biology and Multi-Omics: Turning a Breakthrough Platform Into a Repeatable Sales Engine

by Stephen Manobiano | Jun 29, 2026 | Founders and Business Leaders, news

Spatial transcriptomics, spatial proteomics, and mass spectrometry imaging are converging fast. Researchers can now map gene and protein expression directly inside intact tissue, something no bulk, homogenized sample could ever show them. That’s a genuine scientific...

We cannot wait for the next wave of VC or PE money to solve commercial problems.

by Stephen Manobiano | Jun 18, 2026 | Commercialization, Fractional, news

I’ve spent the last several months at life science conferences, dinners, and networking events, talking to founders, CEOs, and investors. And I keep hearing the same thing, just in different rooms. Investors are stuck with Portfolios they can’t exit. Which...

Are You Wasting Your Money at SLAS Boston?

by Stephen Manobiano | Feb 13, 2026 | Commercialization, news, tradeshows

SLAS Boston is expensive. Booth space. Freight. Travel. Hotels. Sponsorships. Swag.For many life science companies, the total investment quietly creeps into six figures. The real question executives should be asking right now isn’t: “How was the show?” It’s: Did it...

The Future of Biotech Marketing: HubSpot’s “Loop” Framework and Marketing Studio

by Stephen Manobiano | Nov 15, 2025 | AI, CRM best practices, HubSpot, Marketing, news, omnichannel

From Funnels to Loops: How HubSpot’s New Marketing Studio is Transforming Life Science Commercialization In biotech, the way customers discover, evaluate, and buy has changed dramatically. Traditional marketing funnels, linear, rigid, and slow to adapt, are being...